MERCAPTOACETYLAMIDE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE

This invention discloses and claims a series of mercaptoacetylamide derivatives of formula (I). Also disclosed and claimed are pharmaceutical compositions incorporating these compounds and processes for preparing said compounds. The use of said compounds for inhibition of the enzymes angiotensin con...

Full description

Saved in:
Bibliographic Details
Main Authors SEURING, BERNHARD, SEIZ, WERNER, KLEEMANN, HEINZ-WERNER, LINZ, WOLFGANG, GERKEN, MANFRED, ANDERSON, BARBARA ANN, JABLONKA, BERND, MEHDI, SHUJAATH, FLYNN, GARY A, KOEHL, JACK ROGER
Format Patent
LanguageEnglish
Published 25.05.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention discloses and claims a series of mercaptoacetylamide derivatives of formula (I). Also disclosed and claimed are pharmaceutical compositions incorporating these compounds and processes for preparing said compounds. The use of said compounds for inhibition of the enzymes angiotensin converting enzyme and neutral endopeptidase, and for the treatment of hypertension and congestive heart failure are also disclosed and claimed. Ovaj pronalazak otkriva i daje u patentnim zahtevima seriju derivata merkaptoacetilamida formule (I).. Ovde su takodje otkrivene i date u patentnim zahtevima farmaceutske kompozicije koje obuhvataju ova jedinjenja i postupci za pripremanje pomenutih jedinjenja. Upotreba pomenutih jedinjenja za inhibiciiju enzima koji konvertuje angiotenzin i neutralnih endopeptidaza i za lečenje hipertenzije ikongestivnog poremećaja srca su takodje ovde otkriveni i dati u patentnim zahtevima.[This invention discloses and claims a series of mercaptoacetylamide derivatives of formula (I). Also disclosed and claimed are pharmaceutical compositions incorporating these compounds and processes for preparing said compounds. The use of said compounds for inhibition of the enzymes angiotensin converting enzyme and neutral endopeptidase, and for the treatment of hypertension and congestive heart failure are also disclosed and claimed.
Bibliography:Application Number: YUP78703